These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 6177960

  • 1. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 2. Blood lipids and antihypertensive drugs. The Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Pharmacol; 1983; 14 Suppl 2():217-20. PubMed ID: 6632918
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    Br J Clin Pharmacol; 1982; 13(Suppl 2):441S-444S. PubMed ID: 7104158
    [Abstract] [Full Text] [Related]

  • 4. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W, Müller-Wieland D, Nägele H, Behnke B, Greten H.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [Abstract] [Full Text] [Related]

  • 5. The effect on HDL cholesterol of oxprenolol and atenolol.
    Kjeldsen SE, Eide I, Leren P, Foss OP, Holme I, Eriksen IL.
    Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595
    [Abstract] [Full Text] [Related]

  • 6. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 7. Effect of prazosin and propranolol on lipoproteins of hypertensive patients.
    Hurt E, Velasco M, Silva H, Camejo G.
    Biomed Biochim Acta; 1987 Jun; 46(1):111-8. PubMed ID: 3107546
    [Abstract] [Full Text] [Related]

  • 8. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF.
    J Cardiovasc Pharmacol; 1982 Jun; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [Abstract] [Full Text] [Related]

  • 9. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S, Gamez R, Mas R, Goicochea E.
    Int J Tissue React; 2003 Jun; 25(3):81-9. PubMed ID: 14756189
    [Abstract] [Full Text] [Related]

  • 10. Metabolic changes during antihypertensive therapies.
    Krone W, Nägele H.
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
    [Abstract] [Full Text] [Related]

  • 11. Effect of antihypertensive agents on lipid metabolism.
    Cutler R.
    Am J Cardiol; 1983 Feb 24; 51(4):628-31. PubMed ID: 6131603
    [Abstract] [Full Text] [Related]

  • 12. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J, Chanu B, Bakir R, Sauvanet JP.
    J Pharmacol; 1983 Feb 24; 14 Suppl 2():183-99. PubMed ID: 6138467
    [Abstract] [Full Text] [Related]

  • 13. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S, Simons LA, Hickie JB, Chang S.
    Artery; 1990 Feb 24; 17(2):60-70. PubMed ID: 1968740
    [Abstract] [Full Text] [Related]

  • 14. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J, Saku K, Ideishi M, Arakawa K, Kato Y, Kuwano E, So T.
    Clin Ther; 1989 Feb 24; 11(2):219-24. PubMed ID: 2736568
    [Abstract] [Full Text] [Related]

  • 15. [Antihypertensive therapy and lipid metabolism].
    Krone W, Müller-Wieland D, Greten H.
    Klin Wochenschr; 1984 Mar 01; 62(5):193-202. PubMed ID: 6143851
    [Abstract] [Full Text] [Related]

  • 16. Do beta-blockers alter lipids and what are the consequences?
    Holtzman E, Rosenthal T, Goldbourt U, Segal P.
    J Cardiovasc Pharmacol; 1987 Mar 01; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
    [Abstract] [Full Text] [Related]

  • 17. Prazosin improves atherogenic index and inhibits the deleterious effect of dihydrochlorothiazide in patients with essential hypertension.
    Farsang C, Péter M, Balás-Eltes A, Fehér J.
    J Cardiovasc Pharmacol; 1987 Mar 01; 10 Suppl 12():S240-3. PubMed ID: 2455187
    [Abstract] [Full Text] [Related]

  • 18. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R, Zoppi A, Pasotti C, Poletti L, Tettamanti F, Malamani G, Corradi L.
    J Cardiovasc Pharmacol; 1989 Mar 01; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [Abstract] [Full Text] [Related]

  • 19. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P, de Courten M, Ferrari P, Böhlen L.
    J Cardiovasc Pharmacol; 1993 Mar 01; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [Abstract] [Full Text] [Related]

  • 20. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
    Pool JL, Lenz ML, Taylor AA.
    J Hum Hypertens; 1990 Oct 01; 4 Suppl 3():23-33. PubMed ID: 1979819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.